<ul class="summary-bullets"><li>The company had signed a deal with Alliance Global Partners to sell shares worth up to $100 million last October.</li><li>Paranovus has been under pressure to remain compliant with Nasdaq’s listing requirements, prompting the company to implement a reverse share split last December.</li><li>The stock fell below $1 on March 17 and has traded below that level since.</li></ul>Paranovus Entertainment Technology (PAVS) grabbed investor attention in pre-market trading on Tuesday, with shares soaring nearly 65% after the AI-driven entertainment company scrapped its share sale agreement with Alliance Global Partners.&nbsp;This move has removed what many retail investors saw as a dilution overhang on the stock.According to an SEC filing on Monday, the company notified Alliance Global Partners that it was ending the agreement, along with all related arrangements. As of the filing date, the company had sold around 5.9 million Class A ordinary shares under the deal, adjusted for the 1-for-100 reverse stock split completed in December 2025.On Oct. 28, 2025, Paranovus entered into a sales agreement with Alliance Global Partners to raise capital by selling its Class A ordinary shares. The deal allowed the company to sell up to $100 million worth of shares over time through “at-the-market” offerings. The stock declined more than 11% after the announcement.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Following the termination of the share sale agreement, retail sentiment for <a href="https://stocktwits.com/symbol/PAVS">PAVS</a> on Stocktwits flipped to ‘extremely bullish’ from ‘bearish,’ accompanied by ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/PAVS_jpg_4a5813fa32.webp" alt="PAVS.jpg">Chatter was largely bullish, with one user expecting the stock price to double and potentially break past $1.05. The stock is currently trading close to $0.5.<stembedurl>https://stocktwits.com/Pandy1/message/648360403</stembedurl>Another user said that since there is no ‘active overhang,’ the stock is free to rally.<stembedurl>https://stocktwits.com/SHEEPWOLF/message/648357580</stembedurl>One user stated that traders are “likely reading this as the shutdown of a key dilution route.”<stembedurl>https://stocktwits.com/PaulLaurent/message/648356756</stembedurl><h2 class="st-heading-2">Paranovus Faces Compliance Challenge</h2>In December, Paranovus faced a potential delisting from the Nasdaq after failing to meet minimum bid price requirements. The company had traded below $1 for an extended period and later fell to $0.10, triggering the regulatory action. Nasdaq warned that trading could be suspended by late December 2025 unless the company appealed.To address the issue, Paranovus implemented a 1-for-100 reverse stock split to boost its share price to $1. The move helped the company regain compliance with Nasdaq listing rules by early January 2026. However, the stock fell below $1 on March 17 and has traded below that level since.For updates and corrections, email newsroom[at]stocktwits[dot]com.

This Tiny AI Stock Killed A $100M Deal And Is Exploding Pre-Market – Retail Bulls Eye $1 Break

The AI-based entertainment company terminated its share sale agreement with Alliance Global Partners after selling around 5.9 million shares under the deal.

Why Did PAVS Stock Surge 65% In Pre-Market Today?

Equity

<ul class="summary-bullets"><li>Fubo announced a reverse split plan for its Class A and B shares in February.</li><li>Trading will commence on Tuesday on a split-adjusted basis, with the stock retaining its current ticker symbol.</li><li>A reverse split reduces the share count while raising the price; FuboTV combined 12 shares into one.</li></ul>FuboTV Inc. (FUBO) is drawing attention after moving forward with a share restructuring, finalizing a reverse stock split to consolidate its outstanding shares.&nbsp;The move follows earlier approvals by both its board and a key shareholder, signaling a strategic effort to adjust its market positioning.<h2 class="st-heading-2">Shareholder Approval And Board Action</h2>The company confirmed on Monday that Hulu, LLC, which holds sufficient voting power, provided written consent to authorize the stock split. This action followed recommendations from FuboTV’s board and audit committee, culminating in a finalized decision on March 20, to implement a 1-for-12 reverse split.&nbsp;FuboTV formally submitted its Certificate of Amendment on Monday. Shares will begin trading on a split-adjusted basis on Tuesday under the existing ticker symbol. The company also issued a new CUSIP number to reflect the updated structure.<h2 class="st-heading-2">What Are Stocktwits Users Saying?</h2>On Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory while message volume improved to ‘high’ from ‘low’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_24_060945_png_681888ef4e.webp" alt="FUBO’s Sentiment Meter and Message Volume as of 06:00 a.m. ET on Mar. 24, 2026 | Source: Stocktwits" width="926" height="100"><figcaption>FUBO’s Sentiment Meter and Message Volume as of 06:00 a.m. ET on Mar. 24, 2026 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed concern about the stock’s value after the split.&nbsp;<stembedurl>https://stocktwits.com/walkinonsunshine1969/message/648357643</stembedurl>However, a bullish user expects the stock to perform well.&nbsp;<stembedurl>https://stocktwits.com/PhillySpecial2/message/648359225</stembedurl><h2 class="st-heading-2">What The Reverse Split Means</h2>A reverse stock split reduces the number of shares in circulation while proportionally increasing the stock price. In FuboTV’s case, every 12 shares were consolidated into one. Companies often pursue such actions to meet exchange listing requirements or to improve perceived share value.Alongside the split, the company amended its certificate of incorporation to reaffirm its authorized share count. FuboTV retains the ability to issue billions of shares of Class A and Class B common stock, as well as preferred stock, preserving flexibility for future financing or strategic initiatives.In October, FuboTV and The Walt Disney Company (DIS) completed the merger of Fubo’s platform with Hulu + Live TV, forming a combined streaming business that blends Fubo’s sports-focused offerings with Hulu + Live TV’s broader entertainment lineup.In the first quarter (Q1), Fubo reported a 40% year-on-year jump in revenue to $1.549 billion. FUBO stock has gained over 303% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/amc-stock-rises-premarket-project-hail-mary-breakout-opening-fuels-70-ticket-revenue-jump/cZ3nOq7RIKK">AMC Stock Rises Premarket: ‘Project Hail Mary’ Breakout Opening Fuels 70% Ticket Revenue Jump</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of FuboTV Inc. on August 7, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

FUBO Stock Set For Reverse Split– Retail Traders Are Not Convinced, Raise Questions On Valuation After Strong Run

FuboTV said Hulu, which held majority voting power, approved the reverse split after recommendations from the board and audit committee, leading to a final decision on a 1-for-12 split.

<ul class="summary-bullets"><li>The company stated that it intends to use the proceeds of the stock offering to meet its working capital requirements as well as other general corporate needs.</li><li>Last week, Outlook Therapeutics announced a new $18.4 million non-convertible unsecured note financing, stating that it will use a portion of the net proceeds to pay down an existing note.</li><li>In December 2025, the FDA issued a Complete Response Letter for ONS-5010 / LYTENAVA, saying it could not approve the treatment in its current form for wet AMD.</li></ul>Outlook Therapeutics Inc. (OTLK) shares plunged 32% in Tuesday’s pre-market trade after the company announced a proposed public offering of its common stock and accompanying warrants.Outlook Therapeutics announced the pricing of the public offering, stating that each share of common stock and the accompanying warrant are being sold at a combined price of $0.25. The company said it expects aggregate gross proceeds of $5 million and that the offering is expected to close on Wednesday, March 25, 2026.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/OTLK">Outlook Therapeutics</a> trended in the ‘extremely bearish’ territory, with message volumes at ‘high’ levels at the time of writing.<h2 class="st-heading-2">Why Did Outlook Therapeutics Announce The Offering?</h2>Outlook Therapeutics stated that it intends to use the proceeds of the stock offering to meet its working capital requirements as well as other general corporate needs.Last week, the company announced a new $18.4 million non-convertible unsecured note financing, stating that it will use a portion of the net proceeds to pay down an existing note.Earlier this month, Outlook Therapeutics provided an update with respect to a meeting with the U.S. Food and Drug Administration (FDA) regarding the company’s Biologics License Application for its treatment of wet age-related macular degeneration (wet AMD).In December 2025, the company said that the FDA issued a Complete Response Letter for its investigational treatment, ONS-5010 / LYTENAVA (bevacizumab-vikg), stating that it cannot approve the application in its present form for the treatment of wet AMD.The company said that if the FDA approves it, bevacizumab-vikg has the potential to be the first ophthalmic formulation of bevacizumab-vikg approved by the regulator for use in ophthalmology.Bevacizumab-vikg is a lab-made antibody that targets a protein called VEGF, which helps blood vessels grow. By blocking VEGF from binding to its receptors on blood vessel cells, the drug prevents the formation of new blood vessels.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Outlook Therapeutics’ proposed offering was&nbsp;criticized&nbsp;by a user on the platform, who called out the company for not giving a roadmap on how it intends to use the money, other than meeting its working capital and general corporate needs.<stembedurl>https://stocktwits.com/HarveySpecter20/message/648356634</stembedurl>Another user highlighted the lack of data on the uptake of the investigational treatment from patients.<stembedurl>https://stocktwits.com/updownsides/message/648355300</stembedurl><a href="https://stocktwits.com/symbol/OTLK">OTLK stock</a> is down 80% year-to-date and 79% over the past 12 months. The Vanguard Extended Market Index Fund ETF (VXF) is up 16% over the past 12 months, while the iShares Micro-Cap ETF (IWC) is up 38%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fidelity-backs-elon-musk-tesla-spacex-terafab-project-datacenters-in-space/cZ3mK7PRI0u">Elon Musk's Joint Tesla, SpaceX Terafab Project Makes A 'Ton Of Sense', Says Investor Fidelity: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Trading digital board showing the data on global stock market crash. | Image source: Getty Images

Why Is OTLK Stock Falling Today?

Outlook Therapeutics announced the pricing of the public offering, stating that each share of common stock and the accompanying warrant are being sold at a combined price of $0.25.

<ul class="summary-bullets"><li>CMCL forecast 2026 total group capital expenditure of $178.9 million for 2026 to sustain production at the Blanket gold mine in Zimbabwe</li><li>CMCL’s revenue jumped 46% in 2025.</li><li>&nbsp;Stocktwits sentiment jumped to ‘extremely bullish’ from ‘bullish’ a day ago</li></ul>Caledonia Mining Corp. (CMCL) drew heightened retail attention following its quarterly revenue beat on Monday, as investors focused on the company’s development of its gold projects in Zimbabwe.<h2 class="st-heading-2">Caledonia Q4 Snapshot</h2>CMCL reported Monday, fourth quarter earnings of $0.56 per share on revenue of $74.7 million, beating the market’s estimate of $71.9 million, according to data from Fiscal.ai. Last year, the company reported quarterly adjusted earnings of $0.44 per share on revenue of $47.5 million.The gold producer said its full-year revenue jumped 46% to $267.7 million, driven by a higher gold price environment and better sales.<h2 class="st-heading-2">Zimbabwe Mine Could Reshape Growth</h2>On Monday, the company said it expects first production of gold in late 2028 at its Bilboes gold project. CMCL expects the project to produce about 200,000 ounces of gold in its first year of production.The company noted that the mine has a life of 10.8 years, with proven and probable mineral reserves of 1.75 million ounces of gold.Out of the estimated group growth capital expenditure of $135.9 million for the year, CMCL has allocated $132.1 million towards the development of Bilboes, subject to board approval and receipt of funds.CMCL added that the project also has the potential to change its production and profit profile.Caledonia also expects full-year gold production at the Blanket Mine, in the region where it holds a 64% stake, to be between 72,000 and 76,500 ounces.For the year, it expects the mine's quarterly production profile to be stronger in the second half as higher-grade areas come on stream.CMCL added that it plans to use the current gold price to invest in projects at the mine, which will help contain rising input prices.The company is set to pay a quarterly dividend of $0.14 per share on April 17, unchanged from last year.<h2 class="st-heading-2">What Retail Traders Feel About Caledonia</h2>Stocktwits sentiment on CMCL jumped to ‘extremely bullish’ from ‘bullish’ just a week ago, amid ‘extremely high’ message volumes over the last day, even as the stock sits roughly 15% lower year to date. Engagement on the platform has also surged: CMCL’s follower count has jumped 56% over the past year.One user<a href="https://stocktwits.com/FrankenMoney/message/648326475"> said</a>, “When Bilboes opens we can look forward to a 400% increase YoY on pretty much every good metric Beyond that, once we get to 1M ounces per annum we will get an institutional multiple,” <stembedurl>https://stocktwits.com/FrankenMoney/message/648237510</stembedurl>The user<a href="https://stocktwits.com/FrankenMoney/message/648237510"> added</a> “Bloomberg predicts &gt;200% profit gain for 2025 and &gt;18% growth for 2026 and probably &gt;400% growth in 4Q27 when Bilboes is online”<stembedurl>https://stocktwits.com/FrankenMoney/message/648237510</stembedurl>CMCL stock has lost over 16% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

An artisanal miner sifts through crushed ore powder for gold particles at a small-scale gold mine in Zimbabwe. Photographer: Cynthia R Matonhodze/Bloomberg via Getty Images

Is Caledonia Mining Poised For A Profit Boom? Why Retail Traders Are Bullish After Q4 Revenue Beat

The company said it expects first production of gold in late 2028 at its Bilboes gold project in Zimbabwe.

<ul class="summary-bullets"><li>A draft U.S. stablecoin bill reviewed on Monday proposed banning yield on stablecoins across exchanges.</li><li>The proposal prevents interest on stablecoins, marking a shift from earlier discussions that had left room for such incentives.</li><li>&nbsp;Regulators, including the Securities and Exchange Commission, would jointly define permissible rewards within one year under the updated framework.</li></ul>As lawmakers continue to work toward a middle ground between banks and crypto companies, a newly disclosed stablecoin proposal in Washington is once again drawing attention.&nbsp;The latest update to the Digital Asset Market Clarity Act (CLARITY Act) would prohibit platforms from offering yield on stablecoins “directly or indirectly,” including any mechanism deemed “economically or functionally equivalent” to interest.&nbsp;The draft language was reviewed by industry stakeholders following&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/crypto-bank-executives-head-to-capitol-hill-to-review-stablecoin-deal-details-this-week-report/cZ3mg3YRI0S">Monday's meeting</a>,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/EleanorTerrett/status/2036279124382077137?s=20">according</a> to Eleanor Terrett. To curb workarounds, the restriction would apply broadly to digital asset service providers, including exchanges, brokers, and their affiliates.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_24_at_5_28_19_AM_png_7158973a7d.webp" alt="Screenshot 2026-03-24 at 5.28.19 AM.png" width="304" height="446"><figcaption>EEleanor Terrett on new updates on CLARITY Act. Source: @EleanorTerrett/x</figcaption></figure><h2 class="st-heading-2">Limited Room For Rewards – For Now</h2>For now, as long as they are not deemed as “interest”, the proposal allows some activity-based rewards, including loyalty programs, promotions, and subscription incentives.&nbsp;Additionally, within a year, the Securities and Exchange Commission (SEC), the Commodity Futures Trading Commission (CFTC), and the Treasury Department would be required to jointly define what constitutes acceptable rewards and to create anti-evasion regulations. But other aspects of the bill, such as token classification and DeFi provisions, are still being finalized before a possible committee markup.<h2 class="st-heading-2">Industry Continues To Stand Divided</h2>Leaders in the industry who have read the text so far seem to be divided. According to Terrett, some warned that the "economic equivalency" standard is ambiguous and may eventually be applied more narrowly, characterizing the proposal as a "departure" from earlier talks with the White House.&nbsp;Another stated that the new updates are, for the most part, consistent with expectations.&nbsp; Banking representatives are set to review the latest draft next.<h2 class="st-heading-2">Why It Matters For Coinbase, Circle</h2>Stablecoin rewards have been a major source of contention between banks and cryptocurrency companies for a while now. Coinbase (COIN)&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/coinbase-ceo-bullish-on-stablecoins-despite-slowing-growth/cLeJIp8REYg">CEO Brian Armstrong</a> has previously fought against banning yield on stablecoins. Coinbase and its strategic partner, Circle (CRCL), earn revenue from the interest earned on USDC, which they jointly own. While Armstrong has stated that banning yield on stablecoin&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/usdc-rewards-ban-would-help-coinbase-says-ceo/cZR4VRrR4tV">could bring profit&nbsp;</a>to his company, it would hurt US customers the most.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_24_at_5_26_38_AM_png_c2a08a5a06.webp" alt="Screenshot 2026-03-24 at 5.26.38 AM.png" width="483" height="263"><figcaption>COIN retail sentiment on March 24 as of 5:27 a.m. ET | Source: Stocktwits &nbsp;</figcaption></figure><a href="https://stocktwits.com/symbol/COIN">Coinbase stock</a> was down 0.2% in pre-market hours. On Stocktwits, retail sentiment around COIN deteriorated to ‘extremely bearish’ from ‘bearish’, while chatter remained at ‘normal’ levels over the past day.&nbsp; CRCL stock has been down over 15% year-to-date.Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-mag-7-s-p-500/cZ3m1tRRI0H">Is Bitcoin Becoming A MAG 7–Style Trade As It Decouples From The S&amp;P 500?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Congressional Lawmakers Return To Work On Capitol Hill

Stablecoin Yield Ban Proposal Returns – Here’s What It Means For Coinbase, Circle

As discussions around the CLARITY Act continue, key aspects, such as token classification and decentralized finance rules, are still being finalized.

Stablecoin Rewards In Crosshairs: Lawmakers Tighten Crypto Bill Language

Cryptocurrency

<ul class="summary-bullets"><li>Oil stocks rose premarket as Brent held above $102 and traders reassessed escalation risks tied to ongoing disruptions in the Strait of Hormuz.</li><li>Brent has surged about 40% this month as Gulf transit disruptions forced output cuts and raised fears of a widening global energy crunch.</li><li>Analysts said energy markets are tightening at a record pace, warning refined-product markets show the clearest signs of stress.</li></ul>Major oil stocks and index funds traded mixed in premarket trading on Tuesday as crude rebounded after Monday’s sharp selloff, with investors continuing to weigh escalation risks in the Middle East and persistent disruptions to flows through the Strait of Hormuz.<h2 class="st-heading-2">Small-Cap Oil Stocks Jump As Brent Holds Above $102</h2>The United States Oil Fund (USO) rose over 1% and Indonesia Energy (INDO) added nearly 1% in premarket trading on Tuesday, while Battalion Oil (BATL) dropped nearly 6%, EON Resources (EONR) fell about 3%, and Trio Petroleum (TPET) slipped over 1%.Brent crude traded above $102 per barrel, while U.S. benchmark West Texas Intermediate rose about 3%, recovering part of Monday’s roughly 11% decline after U.S. President Donald Trump delayed and threatened strikes on Iran’s energy infrastructure by five days, citing possible negotiations with Tehran. Iran denied talks were underway even as Israel continued attacks.Large-cap energy companies such as Chevron (CVX) and Halliburton (HAL) saw more muted moves as investors instead focused on smaller exploration-linked stocks that tend to react more sharply to short-term crude price swings and geopolitical risk.<h2 class="st-heading-2">Fuel Supply Risks Spread Beyond Middle East</h2>Brent has surged about 40% this month as hostilities involving the United States, Israel and Iran disrupted transit through the Strait of Hormuz, forcing Persian Gulf producers to cut millions of barrels of daily output and raising concerns about a widening global energy crunch.Chile is preparing fuel price increases, Japan ordered a review of its oil-product supply chain, Thailand raised diesel prices, China’s largest refiner prioritized domestic supply, and the Philippines warned that grounding aircraft due to jet-fuel shortages was a “distinct possibility.”Regional tensions also intensified after reports that U.S. allies in the Gulf were moving closer to joining military operations. Saudi Arabia told Washington it was prepared to strike Iran if its infrastructure were targeted, while the Wall Street Journal&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/world/middle-east/iran-gulf-states-offense-decision-b8d98ff9">reported</a> that Crown Prince Mohammed bin Salman was nearing a decision on whether to participate in attacks aimed at restoring deterrence.&nbsp;Iranian Deputy Speaker Ali Nikzad said the Strait of Hormuz would not return to normal conditions and ruled out negotiations with the United States, while gas facilities in Isfahan were struck in the latest escalation.<h2 class="st-heading-2">Saxo: Hormuz Disruption Driving Market Repricing</h2>Ole Hansen, head of commodity strategy at Saxo Bank,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/Ole_S_Hansen/status/2036349803064406070">said on X</a> that crude rebounded after Monday’s slump as traders reassessed escalation risks tied to continued Hormuz disruption.“Global energy markets are tightening at a record pace amid the continued disruption to flows through the Strait of Hormuz,” Hansen said, adding that reports Saudi Arabia and the United Arab Emirates could join the conflict point to further escalation risk. He said the clearest signal of stress currently lies in refined-product markets rather than crude itself.“Crude’s relative resilience may come under increasing pressure as the initial buffer of elevated oil-on-water inventories continues to erode.”<h2 class="st-heading-2">War Premium Keeps Oil Above $100 Outlook</h2>Patrick De Haan, head of petroleum analysis at GasBuddy, said rising fuel prices across the U.S. reflect tightening supply conditions linked to disruptions in the Strait of Hormuz.“Gas prices continued to rise nationwide over the last week as seasonal factors, combined with ongoing supply concerns tied to the continued disruption in the Strait of Hormuz, pushed both gasoline and diesel prices sharply higher,” De Haan said. He added that the national average gasoline price could soon cross a key psychological threshold.Goldman Sachs said Monday’s selloff reflected a partial reassessment of disruption risk. “The market reaction likely reflects some retreat in the perceived risks of lengthy disruptions and of damage to energy assets,” the bank said.Despite the temporary pause in strike threats, analysts said the war premium remains embedded in crude markets. ANZ Research said supply losses have already tightened the global oil balance for the year.Oil prices are expected to remain above $100 per barrel in the near term, the firm said, adding that even if tensions ease, crude is unlikely to return to the $60-$70 range seen previously. ANZ expects oil to average above $90 per barrel in 2026 as disruptions continue reshaping the global supply outlook.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment toward USO was ‘bearish’ amid ‘high’ message volume, while INDO, TPET and BATL also saw ‘bearish’ sentiment amid ‘extremely low’ to ‘low’ message volume. Sentiment for EONR remained ‘neutral’ despite ‘high’ message volume.Over the past year, BATL has surged by over 700%, while USO rose by about 50%, EONR gained roughly 49%, and INDO advanced by around 37%. In contrast, TPET declined about 38% over the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A crane ship helps other vessels searching for oil and natural gas near the oil platform offshore the Red Sea in Ras Behar region, Egypt.

USO, INDO Rise Premarket In Choppy Trade As Hormuz Disruptions Persist: Analyst Says War Premium Keeping Oil Above $100

Small-cap explorers, including TPET, EONR, BATL and INDO outperformed large-cap energy names amid geopolitical supply concerns.

<ul class="summary-bullets"><li>Founder Patrick Soon-Shiong said Abraxane from Bristol Myers Squibb could help boost immune responses when combined with the company’s cancer immunotherapy Anktiva.</li><li>Founder Patrick Soon-Shiong said Abraxane may help “expose” tumors through immune-activating signals and support macrophage activity.</li><li>Anktiva was recently added to Macau’s approved drug list and included by the National Comprehensive Cancer Network for certain bladder cancer patients.</li></ul>Shares of ImmunityBio, Inc. (IBRX)&nbsp;rose over 1% in premarket trading on Tuesday after a newly posted Phase 1 study showed its cancer therapy Anktiva is being tested alongside Bristol Myers Squibb’s Abraxane and other drugs in patients with pancreatic cancer ahead of surgery.<a href="https://stocktwits.com/symbol/IBRX">IBRX stock</a> jumped nearly 11% on Monday, marking its best session in a month.<h2 class="st-heading-2">Phase 1 Trial Tests Anktiva In Pancreatic Cancer</h2>According to a new regulatory update on Monday, the open-label Phase 1 study is evaluating Anktiva in combination with the investigational agents Sotevtamab and Zabadinostat, plus the chemotherapy drugs Gemcitabine and Abraxane, in participants with borderline resectable or locally advanced pancreatic ductal adenocarcinoma.The treatment is being given before surgery, followed by tumor removal and additional immunotherapy afterward, as researchers evaluate the safety and early signals of effectiveness of the combination approach.Participants enrolled in the study will undergo endoscopic ultrasound-guided biopsies of the primary tumor within seven days before treatment begins. Samples will be used for diagnostic evaluation and stored in an approved tissue bank.<h2 class="st-heading-2">Bristol Myers’ Abraxane May Support Anktiva</h2>Soon-Shiong&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/DrPatrick/status/2036321510348947567">said on X</a> that Abraxane differs from older chemotherapy agents such as Taxol because it is delivered using albumin, a naturally occurring protein that helps transport the drug across blood vessel walls into the tumor microenvironment.He said the drug enters tumors through a natural transport pathway called GP60 and helps activate macrophages to attack cancer cells while also “exposing” tumors through DAMP signaling, making them easier for natural killer (NK) cells and T cells to recognize and destroy.“So it’s not that we ignore the use of chemo, it’s how we use it to activate the immune system while protecting and activating the lymphocytes with Anktiva,” Soon-Shiong said. Abraxane was originally developed by Abraxis BioScience, which Soon-Shiong founded, and is now marketed by Bristol Myers Squibb for breast, lung and pancreatic cancers.<h2 class="st-heading-2">Anktiva Platform Therapy Strategy Gains Support</h2>The development adds to ImmunityBio’s broader effort to position Anktiva as a platform immunotherapy that works alongside vaccines, checkpoint inhibitors and chemotherapy backbones across multiple cancer types rather than as a standalone treatment.Last week, Soon-Shiong pointed to&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ibrx-stock-premarket-early-anktiva-immune-data-macau-nod-bull-case/cZ3Xl3sRILc">early immune data</a> from the first 20 participants in an Anktiva study showing increases in absolute lymphocyte counts when the therapy was used with the company’s adenovirus-based cancer vaccine. The trial has enrolled 138 patients randomized to the combination or placebo.He said baseline lymphocyte levels typically decline with age but appeared to increase with Anktiva in the early analysis, supporting the therapy’s immune-stimulating role.<h2 class="st-heading-2">Anktiva Gains Macau Listing, NCCN Backing</h2>Momentum around Anktiva has also been driven by recent regulatory developments, including its addition to&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/ibrx-stock-snap-losing-streak-anktiva-macau-drug-list/cZ3XLBrRIhU">Macau’s approved</a> drug list for bladder cancer. Anktiva now stands alongside therapies from Bristol Myers Squibb, Eli Lilly, Vertex Pharmaceuticals, Gilead Sciences and Moderna in Macau.&nbsp;In the U.S., the National Comprehensive Cancer Network (NCCN) added Anktiva with BCG as an “other recommended” option for papillary bladder cancer that no longer responds to standard BCG treatment, expanding its positioning beyond carcinoma in situ under treatment guidelines.ImmunityBio has also resubmitted its application seeking to expand Anktiva’s label to papillary bladder cancer after previously receiving a refusal-to-file letter from regulators.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for IBRX has slipped to ‘bearish’ levels over the past week from the ‘extremely bullish’ zone amid ‘low’ message volumes over the last 24-hours.<figure class="image"><img src="https://news.stocktwits-cdn.com/ibrx_ss_png_68b9bc5725.webp" alt="ibrx ss.png" width="973" height="145"><figcaption>IBRX sentiment and message volume as of March 24 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/PureLand/message/648355601">said</a> IBRX shares showed signs of steady accumulation after closing near session highs and, citing recent regulatory and guideline momentum. They expect the stock to climb toward $20 by Friday.<stembedurl>https://stocktwits.com/PureLand/message/648355601</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/Dirk1969/message/648354937">said</a> IBRX is “currently the best stock with the most potential.”<stembedurl>https://stocktwits.com/Dirk1969/message/648354937</stembedurl>IBRX stock has surged nearly 250% over the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ImmunityBio logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

IBRX Stock Rises Premarket: Anktiva Moves Into Pre-Surgery Pancreatic Cancer Combo Trial With Bristol Myers Drug

The comments come amid the firm’s strategy to position Anktiva as a platform immunotherapy that works along with vaccines, checkpoint inhibitors and chemotherapy.

<ul class="summary-bullets"><li>Elevated oil prices and Middle East tensions are keeping traders on the edge.</li><li>Investors are eyeing PMI data and GameStop earnings as near-term catalysts for market direction.</li><li>AI stocks remain in focus amid fresh supply chain concerns and geopolitical scrutiny around chip exports.</li></ul>U.S. stock futures rose early Tuesday, attempting to build on the recovery seen in the previous market session. However, investors remain cautious amid the uncertainty in the Middle East. Traders will also be watching for cues from manufacturing data due this morning and Gamestop earnings later today.&nbsp;Crude oil prices rose on concerns that the Iran conflict could reportedly expand to U.S. allies in the Persian Gulf. This comes even as Iranian lawmakers dismissed the possibility of negotiations with the U.S. As of 4:30 a.m. ET on Tuesday, Dow and S&amp;P 500 futures rose 0.2%, and Nasdaq and Russell 2000 futures were up 0.3%.Retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, remained ‘extremely bearish, and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq-100 Index, has remained ‘bearish’ amid high trading volume.&nbsp;Trending Stocks To Watch Nvidia (NVDA):&nbsp;Following the SMCI crisis, U.S. Senators are reportedly demanding a suspension of the AI bellwether’s GPU export licenses to China and Southeast Asia.&nbsp;Broadcom (AVGO):&nbsp;The chipmaker has reportedly warned that its manufacturing partner, TSMC, is nearing capacity for the year, adding to supply concerns.&nbsp;Oracle (ORCL) and Alibaba (BABA):&nbsp;Reports suggest they have launched significant “agentic AI” initiatives.&nbsp;Alibaba has unveiled a new chip design, while Oracle is said to be embedding AI agents in its cloud-based financial software.&nbsp;Amazon (AMZN):&nbsp;The company has said its Bahrain AWS region has been disrupted by drone activity in the Middle East.&nbsp;Gamestop (GME):&nbsp;The video game retailer reports earnings after the bell today. Investors will be tracking any updates on its Bitcoin treasury or an AI-driven pivot.BioCryst Pharmaceuticals (BCRX): The stock is garnering heavy retail attention following takeover speculation.Applied Optoelectronics (AAOI):&nbsp;The stock was trending on Stocktwits following confirmation of a $53 million order for its 800G data center transceivers.&nbsp;Vertiv Holdings Co. (VRT): The stock is on retail radar after it agreed to acquire Italy-based ThermoKey.&nbsp;And&nbsp;Estee Lauder&nbsp;(EL)&nbsp;is reportedly exploring a merger with Puig. Other tickers trending on&nbsp;Stocktwits&nbsp;at the time of writing included Intuitive Machines (LUNR), Micron Technologies (MU), Fastly Inc (FSLY), and The Metals Company (TMC).&nbsp;Other Catalysts To WatchOn the economic front, investors will be tracking the S&amp;P Global Manufacturing &amp; Services PMI at 9:45 am ET. Also, watch out for commentary from&nbsp;Fed Vice Chair for Supervision&nbsp;Michael Barr‘s speech at 6:30 pm ET.&nbsp;On earnings radar, watch out for quarterly reports from&nbsp;Achieve Life Sciences Inc.(ACHV), Greenland Technologies Holding Corp (GTEC), and Huami Corp (ZEPP), before the bell. Meanwhile.&nbsp;Fortress Biotech Inc (FBIO), Durect Corp (DRRX), and Scienture Holdings Inc. (SCNX) are among other companies reporting after market close today.&nbsp; For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Rise Ahead Of PMI Data, Iran Tensions Cap Risk Appetite: Why NVDA, GME, AAOI, BCRX Are Keeping Traders Engaged Today

Data from Stocktwits indicated that retail sentiment has remained bearish on SPY and QQQ for over a week. 

<ul class="summary-bullets"><li>The Ryan Gosling-led Amazon MGM Studios release generated over $140 million globally, including more than $80 million domestically.</li><li>AMC said improving box office trends support expectations that 2026 could become the biggest year for theatrical attendance since 2019.</li><li>The company continues to close underperforming theatres and to refinance about $2.5 billion of debt to extend maturities and preserve liquidity.</li></ul>Shares of AMC Entertainment Holdings (AMC) extended gains into premarket trading on Monday after the world’s largest theatrical exhibitor said the ‘Project Hail Mary’ movie drove over a 70% surge in global ticket revenue in the biggest opening weekend of 2026.<a href="https://stocktwits.com/symbol/AMC">AMC stock</a>&nbsp;rose 1% in early premarket trading after climbing over 4% on Monday to finish at $1.02, its best session in nearly two weeks.<h2 class="st-heading-2">AMC Logs Strongest Weekend Of 2026</h2>AMC said the Ryan Gosling-starrer delivered the company’s strongest opening weekend of the year so far and helped generate its second-highest admissions revenue weekend of 2026 across both its U.S. theatres and international ODEON locations.The Amazon MGM-distributed film recorded a media-reported global opening of more than $140 million, including more than $80 million domestically. The film drew attention as a rare big-budget original sci-fi film, adapted from a bestselling novel by “The Martian” author Andy Weir, positioning it as a potential attendance driver outside traditional franchise titles.“Project Hail Mary is a terrific example of how original storytelling combined with expert marketing of the theatrical experience can resonate with audiences and deliver meaningful results at the box office,” CEO Adam Aron said in a statement.Aron&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/CEOAdam/status/2036069921583428028">noted on X</a> that ‘Project Hail Mary’ is “only one of two non-franchise movies to gross over $80 million in the past decade,” trailing only Oppenheimer in July 2023.<h2 class="st-heading-2">Theatre Attendance Recovery Builds</h2>AMC said the film’s performance adds to the “robust track record” of an increasing box office so far throughout calendar year 2026, adding that the company is “ever more confident that 2026 will wind up being the biggest year since 2019 for moviegoing in theatres.”The company has repeatedly cited a stronger slate of releases over the next two years as a key driver of attendance recovery following several years of disruption tied to the pandemic and Hollywood strikes.<h2 class="st-heading-2">AMC Navigates Macro Headwinds</h2>The extended gains follow a difficult stretch for AMC shares, which remained near record lows last week, with Aron previously calling the broader backdrop “terrible” amid conflict in the Middle East and oil prices soaring above $100 per barrel.Despite macro pressures, the company has maintained that improving industry attendance trends and a stronger film pipeline could support earnings before interest, taxes, depreciation, and amortization (EBITDA) growth if the global box office expands relative to 2025.AMC has also continued working on its operating footprint and balance sheet in recent months, including efforts to close underperforming theatres and refinance roughly $2.5 billion of debt to extend maturities and preserve liquidity as the recovery unfolds.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment toward AMC Entertainment Holdings improved to ‘neutral’ from ‘bearish’ levels seen over the past month, alongside nearly a 300% surge in message volume following the ‘Project Hail Mary’ update.<figure class="image"><img src="https://news.stocktwits-cdn.com/amc_ss_png_e564054f62.webp" alt="amc ss.png" width="970" height="144"><figcaption>AMC sentiment and message volume as of March 24 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/BILLIONSTOBUYBACK/message/648341174">said</a>, “AMC is about to have its BEST YEAR OF THE DECADE.”<stembedurl>https://stocktwits.com/BILLIONSTOBUYBACK/message/648341174</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/65Chevelle/message/648320410">said</a> trading activity in AMC had remained capped below 30 million shares for nearly two weeks and suggested the reported volumes did not reflect underlying market dynamics, adding that “AMC will go down as the death of Shorting!!”<stembedurl>https://stocktwits.com/65Chevelle/message/648320410</stembedurl>AMC stock has plunged 66% over the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Ryan Gosling attends the "Project Hail Mary" New York premiere at Lincoln Center on March 18, 2026 in New York City. (Photo by Stephanie Augello/THR/The Hollywood Reporter via Getty Images)

AMC Stock Rises Premarket: ‘Project Hail Mary’ Breakout Opening Fuels 70% Ticket Revenue Jump 

AMC said improving box office trends support expectations that 2026 could become the biggest year for theatrical attendance since 2019, helped by a stronger upcoming film slate.

<ul class="summary-bullets"><li>The deal adds dry coolers, air-cooled condensers, liquid-cooling systems and microchannel heat-exchange technologies to Vertiv’s end-to-end cooling system.</li><li>CEO Giordano Albertazzi said rising AI workloads are increasing the importance of heat-rejection infrastructure to unlock capacity and improve energy efficiency.</li><li>The deal adds to Vertiv’s broader liquid-cooling expansion strategy, following its $1 billion buy of PurgeRite Intermediate and a separate partnership with Generate Capital.</li></ul>Shares of Vertiv Holdings Co. (VRT)&nbsp;rose 2% in early premarket trading on Tuesday after the company agreed to acquire Italy-based ThermoKey, expanding its thermal infrastructure capabilities for high-density AI data centers.<a href="https://stocktwits.com/symbol/VRT">VRT stock</a> rose marginally on Monday and gained nearly 1% in extended trading.&nbsp;<h2 class="st-heading-2">Vertiv Expands AI Cooling Portfolio</h2>Vertiv said the deal will expand its thermal management portfolio and manufacturing capacity, particularly across Europe, the Middle East and Africa, adding ThermoKey’s dry coolers, air-cooled condensers, liquid-cooling systems and microchannel heat-exchange technologies to strengthen its end-to-end cooling architectures for AI factories and high-density data centers.CEO Giordano Albertazzi said “heat rejection is becoming increasingly critical for data centers and AI factories as the industry seeks new ways to unlock capacity, improve energy efficiency, and scale with confidence.”The company possesses microchannel tech compatible with low-GWP and natural refrigerants and in-house production capacity expected to support Vertiv’s broader thermal portfolio expansion and integration across liquid, air and heat-rejection systems, including TrimCooler solutions. The deal is expected to close in the second quarter of 2026.<h2 class="st-heading-2">AI Infrastructure Shift Gains Momentum</h2>The move comes as investors increasingly shift attention from software-led AI development toward the physical infrastructure needed to run large-scale AI workloads.On Monday, the S&amp;P Dow Jones Indices&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/vrt-lite-cohr-sats-set-to-join-s-and-p-500-as-physical-ai-trade-gains-momentum/cZ3mefMRI0d">added</a> Vertiv alongside Lumentum Holdings, Coherent Corp. and EchoStar to the S&amp;P 500 index, underscoring growing investor focus on the power, cooling and connectivity infrastructure supporting the expansion of AI.Vertiv’s thermal management and power systems are widely used in high-density computing environments where increasingly powerful chips continue to raise cooling requirements and operational complexity.<h2 class="st-heading-2">AI Demand Drives Cooling Expansion</h2>The ThermoKey transaction builds on Vertiv’s broader effort to scale its liquid-cooling and thermal infrastructure capabilities. In November 2025, the company acquired HVAC services provider PurgeRite Intermediate for about $1 billion as part of a push to expand its liquid-cooling services portfolio amid rising pressure on energy systems from AI-driven data-center demand.Earlier this month, Vertiv also announced a collaboration with Generate Capital to deploy integrated power-and-cooling systems designed to help operators accelerate capacity buildouts in power-constrained markets across the U.S.A recent trial involving National Grid, Nvidia, Emerald AI and the Electric Power Research Institute showed AI data centers can rapidly reduce electricity consumption during periods of grid stress without disrupting workloads, highlighting how infrastructure flexibility could ease connection bottlenecks and push deployment timelines, according to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-03-03/ai-data-centers-may-not-need-constant-peak-power-study-finds">report</a>.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for VRT has remained in the ‘bearish’ territory over the past week amid ‘low’ message volume.<figure class="image"><img src="https://news.stocktwits-cdn.com/vrt_ss_png_96a03b1778.webp" alt="vrt ss.png" width="973" height="147"><figcaption>VRT sentiment and message volume as of March 24 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/KineticKash89/message/648265957">said</a>, “AI infrastructure still has real momentum and if the range tightens more this looks ready.”<stembedurl>https://stocktwits.com/KineticKash89/message/648265957</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/CamiVarg/message/648316620">said</a>, “power and data center flow still matter and if buyers stay active this trend can continue”<stembedurl>https://stocktwits.com/CamiVarg/message/648316620</stembedurl>VRT stock has nearly tripled over the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the logo of Vertiv Holdings Co is displayed on a smartphone screen. (Photo illustration by Cheng Xin/Getty Images)

Vertiv Stock Rises Premarket: ThermoKey Buyout Expands Heat-Management Edge In AI Data Center Boom

The move comes as investors shift focus toward AI infrastructure backbone providers, with Vertiv recently added to the S&P 500 alongside peers.

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently trending as shareholders react to the official approval of a 1-for-12 reverse stock split, sparking intense debate over whether this move is a necessary structural correction or a sign of deeper financial distress. While some investors are expressing frustration over stagnant performance and leadership concerns, others are actively tracking heavy call option activity and speculating that the reduced float could set the stage for a potential short squeeze.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing a surge in trading volume and investor interest following unconfirmed market rumors regarding potential M&A activity. Community members are actively debating the credibility of these reports while comparing the stock's current valuation and pipeline potential to past biotech acquisition trends.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is currently seeing intense investor scrutiny and volatility as the community remains deeply divided over the company's financial stability, impending trial readouts, and the performance of current leadership. Investors are actively debating the potential for a Phase 3 SENTRY trial success versus the significant risks posed by high debt levels and the necessity for strategic financing to extend operations.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as traders debate its potential as a low-cap meme coin while community members highlight extreme volatility, aggressive pump-and-dump warnings, and widespread skepticism regarding its long-term viability.

Hesai Group engages in the development, manufacture and sale of three-dimensional light detection and ranging(lidar) solutions. The company’s lidar products enable a broad spectrum of applications across passenger and commercial vehicles with advanced driver assistance systems (ADAS) and autonomous vehicle fleets. The company was founded by Yi Fan Li, Kai Sun, and Shao Qing Xiang in October 2014 and is headquartered in Shanghai, China.

Hesai Group - ADR

Hesai Group is trending following strong guidance for lidar shipments and revenue, alongside a strategic partnership with NVIDIA's AI inspection lab that strengthens its positioning in the autonomous and robotics sectors. While some investors are bullish on the company's market-leading growth and design wins with major OEMs, others are actively debating potential risks related to geopolitical tensions, audit transparency, and competitive threats in the lidar space.

Smithfield Foods, Inc. operates as a meat-processing company. The firm processes and produces pork and hog. Its brands include Smithfield, Eckrich, Nathan's Famous, Farmland, and Armour. The company was founded by Joseph Williamson Luter, Sr. and Joseph Williamson Luter, Jr. in 1936 and is headquartered in Smithfield, VA.

Smithfield Foods, Inc.

Smithfield Foods Inc.

Smithfield Foods is trending as investors digest a strong quarterly earnings report that exceeded consensus estimates for both revenue and EPS. Market participants are actively discussing the company's dividend increase, strategic expansion through the acquisition of the Nathans Famous brand, and the impact of evolving USDA rules on meat processing operations.

Paycom Software, Inc. engages in the provision of cloud-based human capital management software solutions delivered as software-as-a-service. It offers functionality and data analytics that businesses need to manage the complete employment life cycle from recruitment to retirement. The company was founded by Chad R. Richison in 1998 and is headquartered in Oklahoma City, OK.

Paycom Software Inc

Paycom Software (PAYC) is facing heightened volatility and intense community debate as investors react to a challenging leadership landscape, ongoing insider selling, and significant growth deceleration. While some traders are attempting to bottom-fish the stock based on its strong balance sheet and automation potential, many others are expressing deep frustration over the company's corporate culture and disappointing performance guidance.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is under intense scrutiny after announcing a $1B share repurchase program, sparking polarized debate among investors regarding its long-term viability versus rivals like NIO. Community sentiment is deeply divided, with some betting on a rebound supported by the buyback and potential technological pivots, while vocal critics point to shifting delivery momentum, margin pressures, and intense competition from peers as reasons to divest.

BlockDAG is a hybrid concept that combines features of both traditional blockchains and DAGs. It retains the benefits of DAGs, such as high scalability and faster transaction processing, while integrating the security and trust of blockchain consensus mechanisms. BlockDAG emerges as a groundbreaking solution, meticulously merging the strengths of both blockchain and DAG architectures. It leverages the robust security and decentralization of blockchains while incorporating the efficient, scalable transaction processing of DAGs. This strategic integration allows blockDAG to handle a significantly higher volume of transactions at faster speeds compared to traditional blockchains. By overcoming the inherent limitations of both technologies, blockDAG paves the way for a future where distributed ledgers can seamlessly scale to meet the ever-growing demands of the cryptocurrency and broader digital landscape.

BlockDAG

BlockDAG is currently facing intense community scrutiny as investors report significant difficulties claiming tokens, vanishing balances, and confusion regarding liquidity on unauthorized exchanges. While some participants continue to defend the project's long-term potential, many active users are expressing frustration over complex wallet integration hurdles and widespread concerns that the platform may be a long-running exit scam.

Sportradar Group AG engages in the provision of sports betting and entertainment products and services. Its products include Betting Technology & Solutions and Sports Content, Technology & Services. The company was founded by Carsten Marcus Koerl in 2001 and is headquartered in St. Gallen, Switzerland.

Sportradar Group AG - Ordinary Shares - Class A

Sportradar is attracting significant investor attention following a series of analyst upgrades, price target hikes, and strong execution on key partnerships that bolster its market position. The community remains focused on the company's long-term growth potential and its ability to capitalize on the expansion of legal sports betting, with many traders closely monitoring its trajectory as a key infrastructure play in the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


News